COMPARISON OF ENHANCED ELIMINATION OF BISMUTH IN HUMANS AFTER TREATMENT WITH MESO-2,3-DIMERCAPTOSUCCINIC ACID AND D,L-2,3-DIMERCAPTOPROPANE-1-SULFONIC ACID
A. Slikkerveer et al., COMPARISON OF ENHANCED ELIMINATION OF BISMUTH IN HUMANS AFTER TREATMENT WITH MESO-2,3-DIMERCAPTOSUCCINIC ACID AND D,L-2,3-DIMERCAPTOPROPANE-1-SULFONIC ACID, Analyst, 123(1), 1998, pp. 91-92
Two groups of 12 human volunteers, who had been treated with colloidal
bismuth subcitrate, because of Helicobacter pylori-associated gastrit
is, participated in the study, The patients received a single dose of
meso-2,3-dimercaptosuccinic acid (DMSA) or D,L-2,3-dimercaptopropane-1
-sulfonic acid (DMPS) at a dose of 30 mg kg(-1) in a randomized single
blind study, In contrast to DMPS, increasing concentrations of bismut
h in blood were observed during the first 4 h after intake of DMSA, In
urine, both chelators induced a 50-fold increase in urinary bismuth e
xcretion compared with the control urines, The treatment was well tole
rated, The results indicate that both DMSA and DMPS effectively increa
se the elimination of bismuth in human urine, Consequently, both chela
tors may be of benefit in the treatment of patients with bismuth intox
ication.